WuXi AppTec, a global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), announced on Wednesday that it has received a gold medal from EcoVadis for the third consecutive year.
EcoVadis is a sustainability rating agency for global supply chains. Its ratings assess companies based on 21 sustainability criteria across four main themes: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement.
Under the EcoVadis assessment framework, medals are awarded based on a company's percentile ranking, with Gold reserved for the top 5% of companies globally.
"This recognition reflects the significant progress we have made in implementing sustainability and responsible business practices throughout our entire value chain," said Dr. Steve Yang, co-CEO of WuXi AppTec and chairman of WuXi AppTec's Sustainability Committee.
Voyager signs cancer research mission management contract
Pillar Biosciences introduces oncoReveal Myeloid v2 Panel
Mozart Therapeutics presents MTX-101 clinical and preclinical data at EASD Annual Meeting
Moberg Pharma reports new Phase 3 analyses on terbinafine activity in onychomycosis
GE HealthCare to acquire SOFIE Biosciences for USD945m
Ractigen Therapeutics reports positive first-in-human data for RAG-18 in Duchenne muscular dystrophy
AnnJi Pharmaceutical's AJ201 advances into pivotal Phase 3 trial for SBMA
Teva reports new ecopipam data showing tic reduction in Tourette syndrome
Johnson & Johnson reports two-year ICOTYDE data showing sustained clearance in high-impact psoriasis
Clear Scientific reports positive CS-1103 Phase 2 Results in removing fentanyl from the Body
Avimer Bio and CNIO publish JACS study on computational design of self‑assembling protein cages
MHRA approves Zepzelca and atezolizumab as first-line maintenance therapy for ES-SCLC in the UK
Pfizer's tilrekimig shows significant skin clearance in Phase 2 atopic dermatitis study